TY - JOUR
T1 - Core Outcome Measurement Set for Research and Clinical Practice in Post COVID-19 Condition (Long COVID) in Children and Young People
T2 - An International Delphi Consensus Study "PC-COS Children"
AU - PC-COS Children Study Group
AU - Seylanova, Nina
AU - Chernyavskaya, Anastasia
AU - Degtyareva, Natalia
AU - Mursalova, Aigun
AU - Ajam, Ali
AU - Xiao, Lin
AU - Aktulaeva, Khazhar
AU - Roshchin, Philipp
AU - Bobkova, Polina
AU - Aiyegbusi, Olalekan Lee
AU - Anbu, Anbarasu Theodore
AU - Apfelbacher, Christian
AU - Asadi-Pooya, Ali Akbar
AU - Ashkenazi-Hoffnung, Liat
AU - Brackel, Caroline
AU - Buonsenso, Danilo
AU - de Groote, Wouter
AU - Diaz, Janet V
AU - Dona, Daniele
AU - Galvin, Audrey Dunn
AU - Genuneit, Jon
AU - Goss, Helen
AU - Hughes, Sarah E
AU - Jones, Christina J
AU - Kuppalli, Krutika
AU - Malone, Laura A
AU - McFarland, Sammie
AU - Needham, Dale M
AU - Nekliudov, Nikita
AU - Nicholson, Timothy R
AU - Oliveira, Carlos R
AU - Schiess, Nicoline
AU - Segal, Terry Y
AU - Sigfrid, Louise
AU - Thorne, Claire
AU - Vijverberg, Susanne
AU - Warner, John O
AU - Were, Wilson Milton
AU - Williamson, Paula R
AU - Munblit, Daniel
N1 - Funding Information:
the National Institutes of Health (NIH), grant numbers OT2HL161847 and K23AI159518. P.R. Williamson is chair of the Core Outcome Measures in Effectiveness Trials (COMET) Management Group. Other authors declare that they have no competing interests.
Publisher Copyright:
Copyright ©The authors 2024.
PY - 2024/3/1
Y1 - 2024/3/1
N2 - The coronavirus disease 2019 (COVID-19) pandemic substantially impacted different age groups, with children and young people not exempted. Many have experienced enduring health consequences. Presently, there is no consensus on the health outcomes to assess in children and young people with post-COVID-19 condition. Furthermore, it is unclear which measurement instruments are appropriate for use in research and clinical management of children and young people with post-COVID-19. To address these unmet needs, we conducted a consensus study, aiming to develop a core outcome set (COS) and an associated core outcome measurement set (COMS) for evaluating post-COVID-19 condition in children and young people. Our methodology comprised of two phases. In phase 1 (to create a COS), we performed an extensive literature review and categorisation of outcomes, and prioritised those outcomes in a two-round online modified Delphi process followed by a consensus meeting. In phase 2 (to create the COMS), we performed another modified Delphi consensus process to evaluate measurement instruments for previously defined core outcomes from phase 1, followed by an online consensus workshop to finalise recommendations regarding the most appropriate instruments for each core outcome. In phase 1, 214 participants from 37 countries participated, with 154 (72%) contributing to both Delphi rounds. The subsequent online consensus meeting resulted in a final COS which encompassed seven critical outcomes: fatigue; post-exertion symptoms; work/occupational and study changes; as well as functional changes, symptoms, and conditions relating to cardiovascular, neuro-cognitive, gastrointestinal and physical outcomes. In phase 2, 11 international experts were involved in a modified Delphi process, selecting measurement instruments for a subsequent online consensus workshop where 30 voting participants discussed and independently scored the selected instruments. As a result of this consensus process, four instruments met a priori consensus criteria for inclusion: PedsQL multidimensional fatigue scale for "fatigue"; PedsQL gastrointestinal symptom scales for "gastrointestinal"; PedsQL cognitive functioning scale for "neurocognitive" and EQ-5D for "physical functioning". Despite proposing outcome measurement instruments for the remaining three core outcomes ("cardiovascular", "post-exertional malaise", "work/occupational and study changes"), a consensus was not achieved. Our international, consensus-based initiative presents a robust framework for evaluating post-COVID-19 condition in children and young people in research and clinical practice via a rigorously defined COS and associated COMS. It will aid in the uniform measurement and reporting of relevant health outcomes worldwide.
AB - The coronavirus disease 2019 (COVID-19) pandemic substantially impacted different age groups, with children and young people not exempted. Many have experienced enduring health consequences. Presently, there is no consensus on the health outcomes to assess in children and young people with post-COVID-19 condition. Furthermore, it is unclear which measurement instruments are appropriate for use in research and clinical management of children and young people with post-COVID-19. To address these unmet needs, we conducted a consensus study, aiming to develop a core outcome set (COS) and an associated core outcome measurement set (COMS) for evaluating post-COVID-19 condition in children and young people. Our methodology comprised of two phases. In phase 1 (to create a COS), we performed an extensive literature review and categorisation of outcomes, and prioritised those outcomes in a two-round online modified Delphi process followed by a consensus meeting. In phase 2 (to create the COMS), we performed another modified Delphi consensus process to evaluate measurement instruments for previously defined core outcomes from phase 1, followed by an online consensus workshop to finalise recommendations regarding the most appropriate instruments for each core outcome. In phase 1, 214 participants from 37 countries participated, with 154 (72%) contributing to both Delphi rounds. The subsequent online consensus meeting resulted in a final COS which encompassed seven critical outcomes: fatigue; post-exertion symptoms; work/occupational and study changes; as well as functional changes, symptoms, and conditions relating to cardiovascular, neuro-cognitive, gastrointestinal and physical outcomes. In phase 2, 11 international experts were involved in a modified Delphi process, selecting measurement instruments for a subsequent online consensus workshop where 30 voting participants discussed and independently scored the selected instruments. As a result of this consensus process, four instruments met a priori consensus criteria for inclusion: PedsQL multidimensional fatigue scale for "fatigue"; PedsQL gastrointestinal symptom scales for "gastrointestinal"; PedsQL cognitive functioning scale for "neurocognitive" and EQ-5D for "physical functioning". Despite proposing outcome measurement instruments for the remaining three core outcomes ("cardiovascular", "post-exertional malaise", "work/occupational and study changes"), a consensus was not achieved. Our international, consensus-based initiative presents a robust framework for evaluating post-COVID-19 condition in children and young people in research and clinical practice via a rigorously defined COS and associated COMS. It will aid in the uniform measurement and reporting of relevant health outcomes worldwide.
UR - http://www.scopus.com/inward/record.url?scp=85183355776&partnerID=8YFLogxK
U2 - 10.1183/13993003.01761-2023
DO - 10.1183/13993003.01761-2023
M3 - Article
C2 - 38359962
SN - 0903-1936
VL - 63
JO - European Respiratory Journal
JF - European Respiratory Journal
IS - 3
M1 - 2301761
ER -